Attached files

file filename
10-K - 10-K - MYRIAD GENETICS INCd219774d10k.htm
EX-31.2 - EX-31.2 - MYRIAD GENETICS INCd219774dex312.htm
EX-31.1 - EX-31.1 - MYRIAD GENETICS INCd219774dex311.htm
EX-23.1 - EX-23.1 - MYRIAD GENETICS INCd219774dex231.htm
EX-21.1 - EX-21.1 - MYRIAD GENETICS INCd219774dex211.htm
EX-10.15 - EX-10.15 - MYRIAD GENETICS INCd219774dex1015.htm

Exhibit 32

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Annual Report on Form 10-K for the year ended June 30, 2016 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 10, 2016       Date: August 10, 2016

/s/ Mark C. Capone

     

/s/ R. Bryan Riggsbee

Mark C. Capone       R. Bryan Riggsbee
President and Chief Executive Officer       Chief Financial Officer